GINGKO BILOBA Extrait fluide 100 ml

16,00

Description

GINGKO BILOBA  Extrait fluide 100 ml

PROPRIÉTÉS 

Des bienfaits reconnus

Le ginkgo biloba facilite et améliore la circulation sanguine artérielle, veineuse et capillaire. Il optimise l’oxygénation du cerveau, ralentit le vieillissement cellulaire, permet de lutter contre les troubles de la mémoire et participe à soulager les personnes présentant des symptômes liés à la démence sénile. Cette plante médicinale est donc particulièrement recommandée chez les sujets âgés.

Pour se montrer efficaces, les remèdes à base de ginkgo doivent être pris en cures d’au moins trois mois renouvelables.

La recherche sur le ginkgo

Après avoir mis en évidence que le ginkgo avait des effets bénéfiques sur la circulation du sang, notamment au niveau du cerveau, et permettait de soulager les troubles liés au vieillissement, les recherches s’orientent désormais plus précisément vers la maladie d’Alzheimer ou encore la dégénérescence maculaire liée à l’âge (DMLA).

UTILISATION :

Prendre 2 ml dans un verre d’eau trois fois par jour.

INGREDIENTS : Eau, Alcool (30%) ,Gingko biloba .  6 ml d’extrait fluide correspondent à 6 grammes de feuilles de gingko biloba

A consommer dans le cadre d’une alimentation variée et equilibrée . Ne pas dépasser la dose conseillée. Tenir hors de portée des enfants.Ne pas utiliser chez les enfants de moins de 12 ans. Ne pas utiliser chez les femmes enceintes ou allaitantes.;Consultez votre médecin en cas de prise simultanée d’anticoagulants.”

RECHERCHE

. Sierpina VS et al. Ginkgo biloba. Am Fam Physician. 2003 Sep 1;68(5):923-6. Review. Texte integral : www.aafp.org
2. Birks J. et al. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev. 2002;(4):CD003120. Review. Update in: Cochrane Database Syst Rev. 2007;(2):CD003120.
3. Wettstein A. Cholinesterase inhibitors and Gingko extracts–are they comparable in the treatment of dementia? Comparison of published placebo-controlled efficacy studies of at least six months’ durationPhytomedicine. 2000 Jan;6(6):393-401.
4. Kurz A, Van Baelen B. Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: a review based on meta-analyses by the Cochrane collaboration. Dement Geriatr Cogn Disord. 2004;18(2):217-26.
5. Birks J et al. Ginkgo biloba for cognitive impairment and dementia. J. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD003120. Review.
6. Weinmann S et alEffects of Ginkgo biloba in dementia: systematic review and meta-analysisBMC Geriatr. 2010 Mar 17;10:14.
7. DeKosky ST et alGinkgo biloba for prevention of dementia: a randomized controlled trial. Ginkgo Evaluation of Memory (GEM) Study Investigators. JAMA. 2008 Nov 19;300(19):2253-62. Erratum in: JAMA. 2008 Dec 17;300(23):2730. Texte integral : jama.ama-assn.org
8. Andrieu S et alGuidAge study: a 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer’s disease in elderly subjects with memory complaints. i. rationale, design and baseline data. GuidAge study GROUP. Curr Alzheimer Res. 2008 Aug;5(4):406-15.
9. Pittler MH, Ernst E. Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials.Am J Med 2000 Mar;108(4):276-81.
10. Schweizer J, Hautmann C. Comparison of two dosages of ginkgo biloba extract EGb 761 in patients with peripheral arterial occlusive disease Fontaine’s stage IIb. A randomised, double-blind, multicentric clinical trial.Arzneimittelforschung 1999 Nov;49(11):900-4.
11. Pittler MH, Ernst E. Complementary therapies for peripheral arterial disease: systematic reviewAtherosclerosis. 2005 Jul;181(1):1-7. Review.
12. Effect of Ginkgo biloba (EGb 761) on treadmill walking time among adults with peripheral artery disease: a randomized clinical trial. Gardner CD, Taylor-Piliae RE, et alJ Cardiopulm Rehabil Prev. 2008 Jul-Aug;28(4):258-65.
13. Supervised exercise training combined with ginkgo biloba treatment for patients with peripheral arterial disease. Wang J, Zhou S, et alClin Rehabil. 2007 Jul;21(7):579-86.
14. Mix JA, Crews WD Jr. A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findingsHum Psychopharmacol. 2002 Aug;17(6):267-77.
15. Allain H, Raoul P, et alEffect of two doses of ginkgo biloba extract (EGb 761) on the dual-coding test in elderly subjects.Clin Ther 1993 May-Jun;15(3):549-58.
16. Rai GS, Shovlin C, Wesnes KA. A double-blind, placebo controlled study of Ginkgo biloba extract (‘tanakan’) in elderly outpatients with mild to moderate memory impairment.Curr Med Res Opin 1991;12(6):350-5.
17. Mix JA, Crews WD Jr. An examination of the efficacy of Ginkgo biloba extract EGb761 on the neuropsychologic functioning of cognitively intact older adults.J Altern Complement Med 2000 Jun;6(3):219-29.
18. Stough C, Clarke J, et alNeuropsychological changes after 30-day Ginkgo biloba administration in healthy participants.Int J Neuropsychopharmacol 2001 Jun;4(2):131-4.
19. Cieza A, Maier P, Poppel E. Effects of Ginkgo biloba on mental functioning in healthy volunteersArch Med Res. 2003 Sep-Oct;34(5):373-8120.
20. Santos RF, Galduroz JC, et alCognitive performance, SPECT, and blood viscosity in elderly non-demented people using Ginkgo bilobaPharmacopsychiatry. 2003 Jul;36(4):127-33.
21. Solomon PR, Adams F, et alGinkgo for memory enhancement: a randomized controlled trial.JAMA 2002 Aug 21;288(7):835-40.
22. Safety and efficacy of a ginkgo biloba-containing dietary supplement on cognitive function, quality of life, and platelet function in healthy, cognitively intact older adults. Carlson JJ, Farquhar JW, et alJ Am Diet Assoc. 2007 Mar;107(3):422-32.
90 sujets
23. A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline. Dodge HH, Zitzelberger T, et alNeurology. 2008 May 6;70(19 Pt 2):1809-17.Texte integral : www.pubmedcentral.nih.gov
24. Elsabagh S, Hartley DE, File SE. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo bilobaJ Psychopharmacol. 2005 Mar;19(2):173-81.
25. Hartley DE, Elsabagh S, File SE. Gincosan (a combination of Ginkgo biloba and Panax ginseng): the effects on mood and cognition of 6 and 12 weeks’ treatment in post-menopausal womenNutr Neurosci. 2004 Oct-Dec;7(5-6):325-33.
26. Hartley DE, Heinze L, et alEffects on cognition and mood in postmenopausal women of 1-week treatment with Ginkgo bilobaPharmacol Biochem Behav. 2003 Jun;75(3):711-20.
27. Ginkgo biloba is not a smart drug: an updated systematic review of randomised clinical trials testing the nootropic effects of G. biloba extracts in healthy people. Canter PH, Ernst E. Hum Psychopharmacol. 2007 Jul;22(5):265-78. Review.
28. From the Cochrane library: Ginkgo biloba for intermittent claudication. Nicolaï SP, Gerardu VC, et alVasa. 2010 May;39(2):153-8.
29. Supplementing cognitive aging: a selective review of the effects of ginkgo biloba and a number of everyday nutritional substances. Brown LA, Riby LM, Reay JL. Exp Aging Res. 2010 Jan-Mar;36(1):105-22.
30. Roncin JP, Schwartz F, D’Arbigny P. EGb 761 in control of acute mountain sickness and vascular reactivity to cold exposure.Aviat Space Environ Med 1996 May;67(5):445-52.
31. Gertsch JH, Seto TB, et alGinkgo biloba for the prevention of severe acute mountain sickness (AMS) starting one day before rapid ascent.High Alt Med Biol 2002 Spring;3(1):29-37.
32. Chow T, Browne V, et alGinkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trialArch Intern Med. 2005 Feb 14;165(3):296-301.
33. Gertsch JH, Basnyat B, et alRandomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT).BMJ. 2004 Apr 3;328(7443):797.
34. Ginkgo biloba does–and does not–prevent acute mountain sickness. Leadbetter G, Keyes LE, et alWilderness Environ Med. 2009 Spring;20(1):66-71.
35. Ginkgo biloba decreases acute mountain sickness in people ascending to high altitude at Ollagüe (3696 m) in northern Chile. Moraga FA, Flores A, et alWilderness Environ Med. 2007 Winter;18(4):251-7. Erratum in: Wilderness Environ Med. 2008 Spring;19(1):51.
36.Hilton M, Stuart E. Ginkgo biloba for tinnitusCochrane Database Syst Rev. 2004;(2):CD003852. Review.
37. Rejali D, Sivakumar A, Balaji N. Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trialsClin Otolaryngol Allied Sci. 2004 Jun;29(3):226-31.
38. Smith PF, Zheng Y, Darlington CL. Ginkgo biloba extracts for tinnitus: More hype than hope?J Ethnopharmacol. 2005 Aug 22;100(1-2):95-9. Review.
39. Cohen AJ, Bartlik B. Ginkgo biloba for antidepressant-induced sexual dysfunction.J Sex Marital Ther 1998 Apr-Jun;24(2):139-43.
40. Kang BJ, Lee SJ, et alA placebo-controlled, double-blind trial of Ginkgo biloba for antidepressant-induced sexual dysfunctionHum Psychopharmacol. 2002 Aug;17(6):279-84.
41. Wheatley D. Triple-blind, placebo-controlled trial of Ginkgo biloba in sexual dysfunction due to antidepressant drugsHum Psychopharmacol. 2004 Dec;19(8):545-8.
42. Short- and long-term effects of Ginkgo biloba extract on sexual dysfunction in women. Meston CM, Rellini AH, Telch MJ. Arch Sex Behav. 2008 Aug;37(4):530-47.
43. Muir AH, Robb R, et alThe use of Ginkgo biloba in Raynaud’s disease : a double-blind placebo-controlled trialVasc Med 2002;7(4): 265-267.
44. Hyer, Richard. Ginkgo biloba less effective for Raynaud’s disease than nifedipine. Medscape. Medical News, WebMD. [Consulté le 1er avril 2011]. www.medscape.com
45. Reisser CH, Weidauer H. Ginkgo biloba extract EGb 761 or pentoxifylline for the treatment of sudden deafness: a randomized, reference-controlled, double-blind study.Acta Otolaryngol 2001 Jul;121(5):579-84.
46. Burschka MA, Hassan HA, et alEffect of treatment with Ginkgo biloba extract EGb 761 (oral) on unilateral idiopathic sudden hearing loss in a prospective randomized double-blind study of 106 outpatients.Eur Arch Otorhinolaryngol 2001 Jul;258(5):213-9.
47. Tamborini A, Taurelle R. [Value of standardized Ginkgo biloba extract (EGb 761) in the management of congestive symptoms of premenstrual syndrome] [Article en français, résumé en anglais]. Rev Fr Gynecol Obstet 1993 Jul-Sep;88(7-9):447-57.
48. Review on experimental research of herbal medicines with anti-amnesic activity. Hsieh MT, Peng WH, et alPlanta Med. 2010 Feb;76(3):203-17.
49. Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo. Parsad D, Pandhi R, Juneja A. Clin Exp Dermatol. 2003 May;28(3):285-7.
50. Woelk H, Arnoldt KH, et alGinkgo biloba special extract EGb 761 in generalized anxiety disorder and adjustment disorder with anxious mood: a randomized, double-blind, placebo-controlled trialJ Psychiatr Res. 2007 Sep;41(6):472-80.
51. A placebo-controlled study of extract of ginkgo biloba added to clozapine in patients with treatment-resistant schizophrenia. Doruk A, Uzun O, OzÅŸahin A. Int Clin Psychopharmacol. 2008 Jul;23(4):223-7.
52. Anticlastogenic effect of Ginkgo biloba extract in Graves’ disease patients receiving radioiodine therapy. Dardano A, Ballardin M, Ferdeghini M. J Clin Endocrinol Metab. 2007 Nov;92(11):4286-9. Texte intégral : cem.endojournals.org
53. [Effect of extract of Ginkgo biloba on doxorubicin-associated cardiotoxicity in patients with breast cancer] Yi SY, Nan KJ, et alZhongguo Zhong Xi Yi Jie He Za Zhi. 2008 Jan;28(1):68-70. Chinese.
54. Bone K.Ginkgo and ColchicineHerbalGram 55, 2002, American Botanical Council/Herb Research Foundation, pages 24 et 25.
55. Jiang X, Williams KM, et alEffect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjectsBr J Clin Pharmacol. 2005 Apr;59(4):425-32.
56. Engelsen J, Nielsen JD, Hansen KF. [Effect of Coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trialUgeskr Laeger. 2003 Apr 28;165(18):1868-71. Danish.
57. Bent S, Goldberg H, et alSpontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature: a case report and systematic review of the literatureJ Gen Intern Med. 2005;20:657–661.
58. Effect of Ginkgo biloba (EGb 761) and aspirin on platelet aggregation and platelet function analysis among older adults at risk of cardiovascular disease: a randomized clinical trial. Gardner CD, Zehnder JL, et alBlood Coagul Fibrinolysis. 2007 Dec;18(8):787-93.
59. The effect of herbal medicines on platelet function: an in vivo experiment and review of the literature. Beckert BW, Concannon MJ, et alPlast Reconstr Surg. 2007 Dec;120(7):2044-50. Review.
60. Does Ginkgo biloba Special Extract EGb 761®) Provide Additional Effects on Coagulation and Bleeding when Added to Acetylsalicylic Acid 500mg Daily? Wolf HR. Drugs R D. 2006;7:163-72.
61. Potential interaction of Ginkgo biloba leaf with antiplatelet or anticoagulant drugs: what is the evidence? Bone KM. Mol Nutr Food Res. 2008 Jul;52(7):764-71. Review.
62. Yin OQ, Tomlinson B, et alPharmacogenetics and herb-drug interactions: experience with Ginkgo biloba and omeprazolePharmacogenetics. 2004 Dec;14(12):841-50.
64. Myers S. Adulteration Stifles the Ginkgo Biloba Market. Natural Products Insider, 30 octobre 2008. www.naturalproductsinsider.com
65. Does Ginkgo biloba reduce the risk of cardiovascular events? Kuller LH, Ives DG, et al; Ginkgo Evaluation of Memory Study Investigators. Circ Cardiovasc Qual Outcomes. 2010 Jan;3(1):41-7.
66. Effect of Ginkgo biloba on blood pressure and incidence of hypertension in elderly men and women. Brinkley TE, Lovato JF, et al; Ginkgo Evaluation of Memory (GEM) Study Investigators. Am J Hypertens. 2010 May;23(5):528-33.
67. Starling S. Australian regulator attacked over Ginkgo quality. NutraIngredients.com, 29 mai 2009. www.nutraingredients.com
68. Ginkgo biloba (EGb 761) in arteriosclerosis prophylaxis. Siegel G, Schäfer P, et alWien Med Wochenschr. 2007;157(13-14):288-94.
69. Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial. Szczurko O, Shear N, et alBMC Complement Altern Med. 2011 Mar 15;11:21.
70. A systematic review of natural health product treatment for vitiligo. Szczurko O, Boon HS. BMC Dermatol. 2008 May 22;8:2.
71. A randomized, placebo-controlled trial of Ginkgo biloba L. in treatment of premenstrual syndrome. Ozgoli G, Selselei EA, et alJ Altern Complement Med. 2009 Aug;15(8):845-51.
72. Review and meta-analysis of usage of ginkgo as an adjunct therapy in chronic schizophrenia. Singh V, Singh SP, Chan K. Int J Neuropsychopharmacol. 2010 Mar;13(2):257-71.
73. Influence of Ginkgo biloba extract on the pharmacodynamic effects and pharmacokinetic properties of ticlopidine: an open-label, randomized, two-period, two-treatment, two-sequence, single-dose crossover study in healthy Korean male volunteers. Kim BH, Kim KP, Lim KS, Kim JR, Yoon SH, Cho JY, Lee YO, Lee KH, Jang IJ, Shin SG, Yu KS. Clin Ther. 2010 Feb;32(2):380-90.
74. Assessment of health claims, content, and safety of herbal supplements containing Ginkgo biloba. Fransen HP, Pelgrom SM, et alFood Nutr Res. 2010 Sep 30;54.
75. Ginkgo biloba precipitating epileptic seizures. Granger AS. Age Ageing. 2001 Nov;30(6):523-5.

Informations complémentaires

Poids 250 g
Dimensions 5 × 5 × 15 cm

Avis

Il n’y a pas encore d’avis.

Soyez le premier à laisser votre avis sur “GINGKO BILOBA Extrait fluide 100 ml”

Votre adresse de messagerie ne sera pas publiée. Les champs obligatoires sont indiqués avec *